Needham analyst Mike Matson reiterated a Hold rating on Hologic (NASDAQ: HOLX).The analyst commented: "HOLX's F1Q25 revenue was in line ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE